Empower Pharmacy
- 503B
“Compounded medications are fulfilled through Empower Pharmacy, an FDA registered 503B outsourcing facility.”
Source: kernxhealth.com · Verified 2026-08-07
KERNX Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.5/10
Best for: knowing which pharmacy fills the vial — it names Empower Pharmacy
8.5
★★★★☆4.3/5
KERNX Health's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Same price at every dose
Covered by the plan
Medication
In the price
Clinician visits
Charged on top
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at KERNX Health →
Compare top-rated alternatives ↓No insurance needed · Vetted by our editors
Flat monthly plans for compounded semaglutide and tirzepatide, sold out of Washington DC. The physician consultation is not inside that rate; it is billed per visit.
By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $129/moPrice shown up frontFlat across dosesAll 50 statesPharmacy namedNo FDA letter on record
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to KERNX Health
★★★★☆4/5
Editorial score · methodology
$119/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →★★★☆☆3.3/5
Editorial score · methodology
$249/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →★★★★☆4.4/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →KERNX Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $129/mo (Founding rate; standard rate is $249/mo once founding membership closes. A provider consultation fee is charged separ...)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How KERNX Health scores
Six columns, each one computed from something KERNX Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
7.8/10$129/month is 32% below the register median of $189 for compounded semaglutide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
9.0/10names its dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is medium.
Accessibility10%
10.0/10Publishes coverage in 50 of 50 states.
Support10%
4.5/10The price covers medication, shipping.
6weighted dimensions
560sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on KERNX Health
Last checked August 2026- Re-read the price on file across 2 dose or plan tiers
- Checked state coverage: all 50
- Established what the monthly figure covers, and what it leaves out
- Confirmed which compounding pharmacy fills the order, and its accreditation
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with KERNX Health involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1KERNX Health publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3A prescription is dispensed by Empower Pharmacy, which KERNX Health names publicly. Most sellers in this register do not.
- 4The monthly price is recorded as covering medication, shipping.
Price shown before you start
- Cheapest standing monthly prices on record: semaglutide $129, tirzepatide $199. Membership fees, first-month rates and insured copays are excluded from those figures.
- Coverage is published for all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
KERNX Health support, as documented
GLP-1 medications KERNX Health offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Essential plan, month-to-month (founding-member rate)Compounded
$129/mo
semaglutide
Founding rate; standard rate is $249/mo once founding membership closes. A provider consultation fee is charged separately and only when treatment is approved: $25 message-based review, $35 standard live visit, $60 complex live visit.
Premium plan, month-to-month (founding-member rate)Compounded
$199/mo
tirzepatide
Founding rate; standard rate is $299/mo once founding membership closes. A provider consultation fee is charged separately and only when treatment is approved: $25 message-based review, $35 standard live visit, $60 complex live visit.
Check the price yourself before you pay
Every figure here was read off KERNX Health's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
KERNX Health compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that KERNX Health routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
In its favor
- Semaglutide at $129 a month, 32% below the $189 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication and shipping
- Coverage is published for all 50 states
- Names Empower Pharmacy as the dispensing pharmacy, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- Billed separately from the monthly figure: consult
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What KERNX Health charges
KERNX Health does not publish a standing monthly price. That is a choice, and it means you cannot compare it against anything until you have gone through an intake and been quoted. When you get that quote, ask specifically for the ongoing monthly figure and what it includes — not the first-month rate, and not a program total divided by its length.
What KERNX Health dispenses
KERNX Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.
What we could verify
On the record: it treats patients in all 50 states, it dispenses through an accredited compounding pharmacy, and it names the pharmacy that fills its prescriptions. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to compare prices before committing time to an intake — there is no published figure to compare.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- you want the price to stop moving as your dose climbs
- you need access regardless of where you live
Our read
We cannot tell you whether KERNX Health is priced well, because it does not say. That is not automatically disqualifying — plenty of legitimate operators quote after intake — but it does mean the comparison has to happen after you have spent the time, which is the wrong order for the buyer. CoreAge Rx is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
KERNX Health's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Score: 8.5/10Best for: knowing which pharmacy fills the vial — it names Empower Pharmacy
Before you pay KERNX Health
Check today's price, then book the free consultation.
Where KERNX Health is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this KERNX Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See KERNX Health's current pricing
The free consultation is where you learn whether you qualify, and what it costs today.
Not sold on KERNX Health?
Vetted alternatives